Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Shingles in the COVID-19 Era: Increasing Shingles Vaccine Uptake—Audio Recap

Source: Avoid Delay: Shingles Risk and Prevention in the COVID-19 Era and Beyond
What are the barriers to shingles vaccination? What strategies are known to be effective at increasing routine vaccine uptake? Listen to expert insights from Dalilah Restrepo, MD, on shingles vaccination and how healthcare professionals can help their patients catch up on vaccinations delayed due to the COVID-19 pandemic.
person default
Dalilah Restrepo, MD
Released: December 14, 2021

In this episode, Dalilah Restrepo, MD, discusses barriers to shingles vaccination and strategies to increase routine vaccine uptake in the COVID-19 era.

Using the latest data and expert guidance, this podcast covers topics such as:

  • Shingles disease burden and increasing incidence over time
  • Decline in shingles vaccination rates in the COVID-19 era
  • National Vaccine Advisory Committee standards of care
  • CDC guidance catching up after RZV dosing delays
  • Strategies to increase shingles vaccine uptake

Information on this Educational Activity

Faculty

Dalilah Restrepo, MD

Infectious Diseases Specialist
Fountain Valley Hospital
Fountain Valley, California

Dalilah Restrepo, MD, has no relevant conflicts of interest to report.

Program Medium

This program has been made available online.

Acknowledgements

Provided by Clinical Care Options, LLC
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Educational grant provided by
GlaxoSmithKline

Related Content

Clinical Care Options (CCO) module with insights from Dr. Michael Ison on SARS-CoV-2 antivirals and monoclonal antibodies for outpatient treatment

person default Michael G. Ison, MD, MS Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: May 25, 2022 Expired: May 24, 2023

Prof Sharon R. Lewin on treatments for nonhospitalized patients with COVID-19, remdesivir updates, and ivermectin data, from Clinical Care Options (CCO)

Sharon R. Lewin, AO, FRACP, PhD, FAHMS Released: May 24, 2022

Download slides reviewing the latest data and guidance on COVID-19 vaccinations, including authorized and investigational agents, from Clinical Care Options (CCO)

Arthur Kim, MD Sharon R. Lewin, AO, FRACP, PhD, FAHMS Kristen Marks, MD Renslow Sherer, MD Released: May 24, 2022

Prof Cristina Mussini discusses new data from ECCMID 2022 on COVID-19 treatments, vaccination, and long COVID, from Clinical Care Options (CCO)

Cristina Mussini, MD Released: May 23, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings